An interventional study of Non-invasive device for middle ear ventilation in Otitis Media With Effusion, sponsored by Yuinvent Innovations Ltd.. Status unknown. Open to participants aged 4 Years to 10 Years. Per ClinicalTrials.gov, last updated 2019-06-07.
Sponsored by Yuinvent Innovations Ltd. · Not applicable, Interventional, and Treatment
A feasibility study for evaluating efficacy and satisfaction is treated using a non-invasive device for middle ear ventilation.
The study is designed to test the device's effectiveness by encouraging the evacuation of fluid from the middle ear, aid in hearing improvement, pain relief and assessment of patient satisfaction with the use of the device.
284 studies on the registry are indexed under Otitis Media; 33 are open to participants now.
This study's planned enrollment of 40 is below the median of 126 across 194 interventional studies indexed under Otitis Media.
Browse Otitis Media studies →Yuinvent Innovations Ltd. is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Device: Non-invasive device for middle ear ventilation
Daily use of the device
Middle ear values of Tympanometry
Values will be compared to baseline values of Tympanometry
Time frame: 10 weeks
Middle ear ventilation evaluated by otoscopy
Otoscopy evaluation of ear ventilation will be compared to baseline values
Time frame: 10 weeks
Auditory test
Values will be compared to baseline values of Auditory test
Time frame: 10 weeks
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Yuinvent Innovations Ltd.